(VIANEWS) – SCATEC (SCATC.OL), BW LPG (BWLPG.OL), SARTORIUS STED BIO (DIM.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SCATEC (SCATC.OL)
121.2% sales growth and 11.65% return on equity
Scatec ASA, together with its subsidiaries, provides renewable energy solutions worldwide. The company operates through Power Production; Services; and Development & Construction segments. It produces and sells solar, winds, and hydro generated electricity. The company also develops, builds, owns, and operates solar, wind, and hydro power plants and storage solutions. The company is also involved in the engineering, procurement, and construction, as well as operation, maintenance, and asset management of power plants. It has a total of 4.2 GW in operation and under construction. The company was formerly known as Scatec Solar ASA and changed its name to Scatec ASA in November 2020. Scatec ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SCATEC has a trailing twelve months EPS of kr4.24.
PE Ratio
SCATEC has a trailing twelve months price to earnings ratio of 20.64. Meaning, the purchaser of the share is investing kr20.64 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.65%.
Volume
Today’s last reported volume for SCATEC is 135918 which is 60.68% below its average volume of 345744.
More news about SCATEC.
2. BW LPG (BWLPG.OL)
31.1% sales growth and 20.16% return on equity
BW LPG Limited, an investment holding company, engages in ship owning and chartering activities worldwide. The company operates through Shipping and Product Services segments. The company involved in the transportation of liquefied petroleum gas to oil companies, and trading and utility companies. It also offers integrated liquified petroleum gas (LPG) delivery services and support; wholesale and trade of LPG; and management services. It owns and operates LPG vessels and a fleet of very large gas carriers. The company was formerly known as BW Gas LPG Holding Limited and changed its name to BW LPG Limited in September 2013. BW LPG Limited was founded in 1935 and is headquartered in Singapore.
Earnings Per Share
As for profitability, BW LPG has a trailing twelve months EPS of kr39.03.
PE Ratio
BW LPG has a trailing twelve months price to earnings ratio of 5.11. Meaning, the purchaser of the share is investing kr5.11 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.16%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 114% and 6%, respectively.
Volume
Today’s last reported volume for BW LPG is 143819 which is 71.86% below its average volume of 511260.
Yearly Top and Bottom Value
BW LPG’s stock is valued at kr199.40 at 17:20 EST, way higher than its 52-week high of kr121.70.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 26, 2023, the estimated forward annual dividend rate is 39.9 and the estimated forward annual dividend yield is 33.62%.
More news about BW LPG.
3. SARTORIUS STED BIO (DIM.PA)
12.2% sales growth and 8.15% return on equity
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.
Moving Average
SARTORIUS STED BIO’s worth is way above its 50-day moving average of €188.82 and way higher than its 200-day moving average of €219.17.
More news about SARTORIUS STED BIO.
4. VERALLIA (VRLA.PA)
6% sales growth and 46.92% return on equity
Verallia Société Anonyme manufactures and sells glass packaging products for beverages and food products worldwide. It provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.01.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.99. Meaning, the purchaser of the share is investing €8.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.92%.
Sales Growth
VERALLIA’s sales growth is 27.9% for the present quarter and 6% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 3.9B for the twelve trailing months.
Yearly Top and Bottom Value
VERALLIA’s stock is valued at €36.04 at 17:20 EST, way below its 52-week high of €44.86 and way above its 52-week low of €29.56.
More news about VERALLIA.
